A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.18
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.18
NBTH 12.50
AVEW 0.00
38.15 -0.27 (-0.70%) MRK

Click Here to Receive Instant E-mail and RSS Alerts


Trade MRK now with

Stock Details

Last Trade:38.15 Change:-0.27 (-0.70%) Prev Close:38.42 Open: 38.39 Days Range:38.14 – 38.52 52 Week Range: 29.47 - 39.43 Volume:9595270 P/E: 18.89
EPS:2.02

Member Comments

No member comments available for MRK


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon

Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00. Analyst, Jeffrey Frelick, said, "While still mostly a catalyst story, quarterly results were in line to slightly ahead of expectations. The Q1/12... Read More

Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Recent Alert on 02/07/12 at 8:31am
Merck (MRK) Issues Top-Line Results for TRA-2P Study of Vorapaxar
Recent Alert on 02/06/12 at 1:54pm
Unusual 11 Midday Movers 02/06: (SURW) (CHUX) (BLRX) HIGHER; (SOHU) (MHS) (CYOU) Lower

View AllRecent Press Releases

Press Release on 02/08/12 at 3:00pm
Thomas E. Shenk To Retire From Merck's Board of Directors
Press Release on 02/07/12 at 9:00am
Perception, Opportunity in Volatility - Research & Analysis on Human Genome Sciences and Merck & Co., Inc.
Press Release on 02/07/12 at 8:30am
Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar
Press Release on 02/06/12 at 8:45am
Merck Provides Update on Development Program for Suvorexant, an Investigational Orexin Receptor Antagonist for the Treatment of Insomnia

View AllRecent SEC Filings

SEC Filing on 02/09/12 at 4:16pm
Form SC 13G/A Merck & Co. Inc. Filed by: Capital Research Global Investors
SEC Filing on 02/09/12 at 10:31am
Form 4 Merck & Co. Inc. For: Feb 08 Filed by: Deese Willie A
SEC Filing on 02/09/12 at 9:08am
Form 8-K Merck & Co. Inc. For: Feb 08

View AllRecent Blog Posts

Blog Posts on 02/09/12 at 4:28pm
Consider These 5 Stocks For The Long Term
Blog Posts on 02/09/12 at 3:14pm
Sanofi's Balanced Model Looks Undervalued
Blog Posts on 02/09/12 at 2:41pm
$10 Billion Market Opportunity For Oculus
Blog Posts on 02/09/12 at 11:28am
Lorillard: A 5.5% Yielder Gaining Momentum
Blog Posts on 02/09/12 at 7:13am
5 Pharmaceutical Stocks To Consider Now